Company Overview
Snapshot
Founded in October 2022 by Nir Sinai and Adiel Barak, Supra Medical operates with 1–10 employees. The company has secured funding across two Seed rounds from Alon MedTech Ventures, with its most recent funding round occurring in August 2025.
Business overview
Supra Medical is a medical device startup focused on ophthalmic drug delivery within the Health Tech & Life Sciences sector. The company is developing an in-office injector for the suprachoroidal space, designed to simplify the effective, efficient, and safe administration of drugs for various eye conditions. Its innovative system enables ophthalmologists to perform suprachoroidal drug administration, improving outcomes and paving the way for gene therapies, ultimately aiming to enhance patient vision and quality of life. The company operates in the Pharma & Medical Biotechnology and Drug Delivery sub-sectors, targeting the Healthcare & Life Sciences market, specifically Biotechnology and Pharmaceuticals, with a B2B business model.
Log in to access full profile ›Company Intelligence Q&A
- When was Supra Medical founded?
- Supra Medical was founded in October 2022 by Nir Sinai and Adiel Barak.
- What is Supra Medical's core product?
- Supra Medical's core product is an innovative in-office injector for the suprachoroidal space, designed for safe and effective ophthalmic drug administration.
- What is the primary market Supra Medical serves?
- Supra Medical primarily serves the Healthcare & Life Sciences market, focusing on ophthalmologists and patients requiring treatments for various eye conditions.
- When did Supra Medical last raise funding?
- Supra Medical secured its Seed funding round in August 2025 from Alon MedTech Ventures.
- Which investor has participated in Supra Medical's funding rounds?
- Alon MedTech Ventures has participated in Supra Medical's Seed funding rounds, leading the round in November 2022 and following on in August 2025.